Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to ...

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.